trending Market Intelligence /marketintelligence/en/news-insights/trending/oLUWd0jjoF2NlDEP_EI-Uw2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Novogen to change name, consolidate stocks

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Novogen to change name, consolidate stocks

Novogen Ltd is seeking shareholder approval to change its name to Kazia Therapeutics Ltd. and to consolidate its shares.

Novogen intends to implement a 1-for-10 share consolidation to have a more appropriate capital structure as well as reduce administrative costs resulting from a large number of issued shares.

The share consolidation is expected to be effective Dec. 31.